Ancillary therapies for acute respiratory distress syndrome

International Anesthesiology Clinics

Volumn 37, Issue 3, 1999, Pages 65-83

  Kwo, Jean ^a   Bigatello, Luca M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; NITRIC OXIDE; NITROUS OXIDE; PROSTACYCLIN; PROSTAGLANDIN E1; SURFACTANT;

ARTIFICIAL VENTILATION; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; GAS EXCHANGE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; REVIEW; VASODILATATION;

EID: 0032768693     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004311-199903730-00008     Document Type: Review

References (66)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149(3, pt. 1):818-824
2. Milberg JA, Davis DR, Steinberg KP, Hudson LD. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA 1995;273(4):306-309
3. Bigatello LM, Greene RE, Sprung CL, et al. HA-1A in septic patients with ARDS: results from the pivotal trial. Intensive Care Med 1994;20:328-334
4. Bernard GR, Wheeler AP, Russell JA, et al. The effects of ibuprofen on the physiology and survival of patients with sepsis. N Engl J Med 1997;336(13):912-918
5. Yu M, Tomasa G. A double-blind, prospective, randomized trial of ketoconazole, a thromboxane synthetase inhibitor, in the prophylaxis of the adult respiratory distress syndrome. Crit Care Med 1993;21(11):1635-1643
6. Meduri GU, Chinn AJ, Leeper KV, et al. Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome. Chest 1994;105:1516-1527
7. Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998;280:159-165
8. Gunther A, Siebert C, Schmidt R, et al. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996;153:176-184
9. Weg JG, Balk RA, Tharratt RS, et al. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress. JAMA 1994;272:1433-1438
10. Anzueto A, Baughman RP, Guntupalli KK, et al. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 1996;334:1417-1421
11. Lewis JF, Goffin J, Yue P, et al. Evaluation of exogenous surfactant treatment strategies in an adult model of acute lung injury. J Appl Physiol 1996;80:1156-1164
12. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharm 1991;41:485-490
13. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405
14. Bigatello LM, Hurford WE, Kacmarek RM, et al. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Effects on pulmonary hemodynamics and oxygenation. Anesthesiology 1994;80:761-770
15. Manktelow C, Bigatello LM, Hess D, Hurford WE. Physiologic determinants of the response to inhaled nitric oxide in patients with acute respiratory distress syndrome. Anesthesiology 1997;87:297-307
16. Zapol WM. Pulmonary circulation during adult respiratory distress. In: Zapol WM, Falke KJ, eds. Acute respiratory failure. New York: Marcel Dekker, 1985:241
17. Radermacher P, Santak B, Becker H, Falke KJ. Prostaglandin E1 and nitroglycerin reduce pulmonary capillary pressure but worsens ventilation-perfusion distributions in patients with adult respiratory distress syndrome. Anesthesiology 1989;70:601-606
18. Radermacher P, Santak B, Falke KJ. Comparison of prostaglandin E1 and nitroglycerin in patients with ARDS. Prog Clin Biol Res 1987;301:267-270
19. Bone RC, Slotman G, Maunder R, et al. Randomized double-blind, multicenter study of prostaglandin E1 in patients with the adult respiratory distress syndrome. Prostaglandin E1 Study Group. Chest 1989;96:114-119
20. Zwissler B, Kemming G, Habler O, et al. Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:1671-1677
21. Hess D, Ritz R, Branson RD. Delivery systems for inhaled nitric oxide. Respir Care Clin North Am 1997;3:371-410
22. Imanaka H, Hess D, Kirmse M, et al. Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation. Anesthesiology 1997;86(3):676-688
23. Kirmse M, Hess D, Fujino Y, et al. Delivery of inhaled nitric oxide using the Ohmeda INOvent delivery system. Chest 1998;113:1650-1657
24. Ceccarelli P, Bigatello LM, Hess D, et al. Nitric oxide delivery with anesthesia machines (abstract). Am J Resp Crit Care Med 1999 (in press)
25. Gerlach H, Rossaint R, Pappert D, Falke KJ. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with the adult respiratory distress syndrome. Eur J Clin Invest 1993;23:499-502
26. Roberts JD Jr, Roberts CT, Jones RC, et al. Continuous nitric oxide inhalation reduces pulmonary arterial structural changes, right ventricular hypertrophy, and growth retardation in the hypoxic newborn rat. Circ Res 1995;76:215-222
27. Dellinger RP, Zimmerman JL, Taylor RW, et al. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26:15-23
28. Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 1998;157:1372-1380
29. Holzmann A, Bloch KD, Sanchez LS, et al. Hyporesponsiveness to inhaled nitric oxide in isolated, perfused lungs from endotoxin-challenged rats. Am J Physiol 1996; 271:L981-986
30. Harris RS, Willey-Courand DB, Kwo J, Venegas JG. Nitric oxide (NO) uptake in lung lavage and pulmonary artery occlusion (abstract). Am J Respir Crit Care Med 1999 (in press)
31. Harris RS, Hess D, Kwo J, et al. Decreased PEEP reduces the nitric oxide (NO) diffusing capacity (DLNO) in ARDS patients (abstract). Am J Resp Crit Care Med 1999 (in press)
32. Stewart TE, Valenza F, Ribeiro SP, et al. Increased nitric oxide in exhaled gas as an early marker of lung inflammation in a model of sepsis. Am J Respir Crit Care Med 1995;151:713-718
33. Krafft P, Fridrich P, Fitzgerald RD, et al. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 1996;109:486-493
34. Kinsella JP, Torielli F, Ziegler JW, et al. Dipyridamole augmentation of response to nitric oxide. Lancet 1995;346:647-648
35. Payen D, Muret J, Beloucif S, et al. Inhaled nitric oxide, almitrine infusion, or their coadministration as a treatment of severe hypoxemic focal lung lesions. Anesthesiology 1998;89:1157-1165
36. Payen DM, Gatecel C, Plaisance P. Almitrine effect on nitric oxide inhalation in adult respiratory distress syndrome. Lancet 1993;341:1664
37. Wysocki M, Delclaux C, Roupie E, et al. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med 1994;20:254-259
38. Doering EB, Hanson CW, Reily DJ, et al. Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 1997;87:18-25
39. Kubes P, Kanwar S, Niu XF, Gaboury JP. Nitric oxide synthesis inhibition induces leukocyte adhesion via superoxide and mast cells. FASEB J 1993;7:1293-1299
40. Ialenti A, Ianaro A, Moncada S, Di Rosa M. Modulation of acute inflammation by endogenous nitric oxide. Eur J Pharmacol 1992;211:177-182
41. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 1991;88:4651-4655
42. Kavanagh BP, Mouchawar A, Goldsmith J, Pearl RG. Effects of inhaled NO and inhibition of endogenous NO synthesis in oxidant-induced acute lung injury. J Appl Physiol 1994;76:1324-1329
43. Lu YT, Liu SF, Mitchell JA, et al. The role of endogenous nitric oxide in modulating ischemia-reperfusion injury in the isolated blood-perfused rat lung. Am J Respir Crit Care Med 1998;157:273-279
44. Bacha EA, Herve P, Murakami S, et al. Lasting beneficial effect of short-term inhaled nitric oxide on graft function after lung transplantation. Paris-Sud University Lung Transplantation Group. J Thorac Cardiovasc Surg 1996;112:590-598
45. Meyer KC, Love RB, Zimmerman JJ. The therapeutic potential of nitric oxide in lung transplantation. Chest 1998;113:1360-1371
46. Chatte G, Sab JM, Dubois JM, et al. Prone position in mechanically ventilated patients with severe acute respiratory failure. Am J Respir Crit Care Med 1997;155:473-478
47. Mure M, Martling CR, Lindahl SG. Dramatic effect on oxygenation in patients with severe acute lung insufficiency treated in the prone position. Crit Care Med 1997;25: 1539-1544
48. Pappert D, Rossaint R, Slama K, et al. Influence of positioning on ventilation-perfusion relationships in severe adult respiratory distress syndrome. Chest 1994;106:1511-1516
49. Walther SM, Domino KB, Glenny RW, et al. Pulmonary blood flow distribution has a hilar-to-peripheral gradient in awake, prone sheep. J Appl Phys 1997;82:678-685
50. Kallas HJ, Domino KB, Glenny RW, et al. Pulmonary blood flow redistribution with low levels of positive end-expiratory pressure. Anesthesiology 1998;88:1291-1299
51. Pelosi P, Tubiolo D, Mascheroni D, et al. Effects of the prone position on respiratory mechanics and gas exchange during acute lung injury. Am J Respir Crit Care Med 1998;157:387-393
52. Fuhrman BP, Paczan PR, DeFrancisis M. Perfluorocarbon-associated gas exchange. Crit Care Med 1991;19:712-722
53. Hirschl RB, Pranikoff T, Gauger P, et al. Liquid ventilation in adults, children, and full-term neonates. Lancet 1995;346:1201-1202
54. Hirschl RB, Pranikoff T, Wise C, et al. Initial experience with partial liquid ventilation in adult patients with the acute respiratory distress syndrome. JAMA 1996;275:383-389
55. Quintel M, Hirschl RB, Roth H, et al. Computer tomographic assessment of perfluorocarbon and gas distribution during partial liquid ventilation for acute respiratory failure. Am J Respir Crit Care Med 1998;158:249-255
56. Kirmse M, Fujino Y, Hess D, Kacmarek RM. Positive end-expiratory pressure improves gas exchange and pulmonary mechanics during partial liquid ventilation. Am J Respir Crit Care Med 1998;158:1550-1556
57. Hirschl RB, Conrad S, Kaiser R, et al. Partial liquid ventilation in adult patients with ARDS: a multicenter phase I-II trial. Ann Surg 1998;228:692-700
58. Bernard GR, Luce JM, Sprung CL, et al. High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987;317:1565-1570
59. Bone RC, Fisher CJ Jr, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987;317:653-658
60. Meduri GU, Headley S, Tolley E, et al. Plasma and BAL cytokine response to corticosteroid rescue treatment in late ARDS. Chest 1995;108:1315-1325
61. Zhu GF, Sun B, Niu SF, et al. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;158:437-443
62. Gommers D, Hartog A, van Veen A, Lachmann B. Improved oxygenation by nitric oxide is enhanced by prior lung re-aeration with surfactant, rather than positive end-expiratory pressure, in lung-lavaged rabbits. Crit Care Med 1997;25:1868-1873
63. Uchida T, Nakazawa K, Yokoyama K, et al. The combination of partial liquid ventilation and inhaled nitric oxide in the severe oleic acid lung injury model. Chest 1998; 113:1658-1666
64. Papazian L, Bregeon F, Gaillat F, et al. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998;157:580-585
65. Fratacci MD, Frostell CG, Chen TY, et al. Inhaled nitric oxide. A selective pulmonary vasodilator of heparin-protamine vasoconstriction in sheep. Anesthesiology 1991;75: 990-999
66. Gattinoni L, Pelosi P, Vitale G, et al. Body position changes redistribute lung computed tomographic density in patients with acute respiratory failure. Anesthesiology 1991; 74:15-23